Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials

INTRODUCTION: There are limited data from randomized controlled clinical trials on the outcomes of biologics after discontinuation of a different systemic therapy. To determine the efficacy of adalimumab in patients who previously received systemic therapy (including failed therapy), we performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Kim A., Armstrong, April W., Reich, Kristian, Karunaratne, Mahinda, Valdecantos, Wendell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733136/
https://www.ncbi.nlm.nih.gov/pubmed/26547918
http://dx.doi.org/10.1007/s40257-015-0161-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733136/
https://www.ncbi.nlm.nih.gov/pubmed/26547918
http://dx.doi.org/10.1007/s40257-015-0161-5

Ejemplares similares